AI brings savings to clinical trials: study

AI is revolutionizing clinical trials by reducing costs and improving efficiency, particularly in cancer treatment research. The study highlights how AI can streamline processes such as patient recruitment and data interpretation, potentially cutting months off trial timelines. This could lead to more resources being allocated to clinical studies, which is crucial given the high failure rate of new drugs. The implications are significant, suggesting that AI could play a pivotal role in making drug development more sustainable and less expensive.